An open-label, multicentre safety study of vemurafenib in patients with BRAF(V600)-mutant metastatic melanoma : final analysis and a validated prognostic scoring system

Larkin, James; Brown, Michael P.; Arance, Ana M.; Hauschild, Axel; Queirolo, Paola; Del Vecchio, Michele; Ascierto, Paolo A.; Krajsova, Ivana; Schachter, Jacob; Neyns, Bart; Garbe, Claus; Sileni, Vanna Chiarion; Mandala, Mario; Gogas, Helen; Espinosa, Enrique; Hospers, Geke; Lorigan, Paul; Nyakas, Marta; Guminski, Alex; Liszkay, Gabriela; Rutkowski, Piotr; Miller, Wilson, Jr.; Donica, Margarita; Makrutzki, Martina; Blank, Christian

An open-label, multicentre safety study of vemurafenib in patients with BRAF(V600)-mutant metastatic melanoma : final analysis and a validated prognostic scoring system

Autor(en):

Larkin, James; Brown, Michael P.; Arance, Ana M.; Hauschild, Axel; Queirolo, Paola; Del Vecchio, Michele; Ascierto, Paolo A.; Krajsova, Ivana; Schachter, Jacob; Neyns, Bart; Garbe, Claus; Sileni, Vanna Chiarion; Mandala, Mario; Gogas, Helen; Espinosa, Enrique; Hospers, Geke; Lorigan, Paul; Nyakas, Marta; Guminski, Alex; Liszkay, Gabriela; Rutkowski, Piotr; Miller, Wilson, Jr.; Donica, Margarita; Makrutzki, Martina; Blank, Christian

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

European Journal of Cancer (2019), Bd. 107, S. 175-185

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2018.11.018

ISSN:

1879-0852